AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES
Author discusses antiatherosclerotic effects of dihydropyridine calcium channel blocker, amlodipine, in patients with coronary artery disease. Results of randomized clinical trials PREVENT (2000), CAPARES (2000), CAMELOT (2004) and ENCORE II (2009) are analyzed.
Saved in:
Main Author: | Yu. M. Lopatin (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antithrombotic and Antiatherosclerotic Properties of Olive Oil and Olive Pomace Polar Extracts in Rabbits
by: Nektaria Tsantila, et al.
Published: (2007) -
AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION
by: A. A. Tarasov, et al.
Published: (2016) -
STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR
by: Olesya A. Puchenkova, et al.
Published: (2020) -
AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY
by: V. M. Tsareva, et al.
Published: (2016) -
Cardio classics revisited: focus on the role of amlodipine
by: Owen AJ, et al.
Published: (2012)